Cardiac amyloidosis was once considered untreatable. Now, we have effective treatments, less invasive diagnostic tests, and a growing body of research in this complex disease.
New AHA guidelines highlight the benefits of SGLT2i medications for patients with heart failure and advances in diagnosing and treating ATTR amyloidosis.
Many patients think 10,000 steps per day is a magic number for their health, but Lifestyle Medicine expert Bethany Agusala, M.D., says any significant increase in steps can be beneficial for our health.
Caffeine is a daily habit for many U.S. kids and teens. Pediatric cardiologist Colin Kane, M.D., discusses how caffeine affects kids’ health, plus tasty beverage swaps.
New technology uses sound waves to unclog arteries and improve how stents work for coronary artery disease. Explore intravascular lithotripsy on the MedBlog.
Rina Mauricio, M.D., explains how UT Southwestern's expert cardio-obstetrics team collaborates to provide the best care for pregnant patients with heart conditions.
A surprise finding in SGLT2 inhibitor drug research has revealed a potentially groundbreaking heart failure treatment. Learn more from Darren McGuire, M.D.
The concept of regenerating or growing heart tissue is not far-fetched. Ongoing research by UT Southwestern may potentially change the future of care for patients with mild to moderate heart disease.
Coffee can make the heart skip a beat, but that might be OK. UT Southwestern discusses the findings from the CRAVE study on how coffee can affect heart health, sleep, and exercise.
Video visits are an effective, high-quality alternative to in-clinic visits for patients with advanced heart failure. Find out what to expect and how remote care can benefit patients.
VSD, or ventricular septal defect, is a complication in 1/1,000 patients who don't get ER care for a heart attack – and 97% die within a year of suffering this complication. This procedure is the last chance to save their lives.
